Schedule M Compliant Pharma Plant Baddi: Industry Standards and Future Outlook for 2026
Baddi, located in Himachal Pradesh, has long been recognized as one of India’s most prominent pharmaceutical manufacturing hubs. Over the years, the region has attracted numerous pharma companies due to its favorable industrial policies, infrastructure, and strategic location. In recent times, the focus has shifted toward stricter regulatory compliance, especially with the implementation of updated guidelines. As a result, the concept of a Schedule M Compliant Pharma Plant Baddi has gained significant attention across the pharmaceutical industry. Schedule M, under the Drugs and Cosmetics Act, outlines Good Manufacturing Practices (GMP) for pharmaceutical production in India. These guidelines ensure that medicines are consistently produced and controlled according to quality standards. With recent revisions, the emphasis on hygiene, documentation, quality control, and infrastructure has increased, making compliance more detailed and structured. A Revised Schedule M plant in Bad...